Kathrin Heinrich
@heinrich_katGI Oncologist, passionate about #precisionmedicine. #WomenInMedicine. @OncoAlert 🚨 Associate Faculty! Views are my own.
Similar User
@BenWestphalen
@LizzySmyth1
@A_DAlessioMD
@FlorianLordick
@YJanjigianMD
@SophiaStock_
@AIO_Onkologie
@KoheiShitara
@sara_lonardi1
@LMU_HaemOnk
@MyriamChalabi
@A_Cammarota_
@ILSONDavid
@dgho_eV
@giusvisc
The path to power is still a maddening tightrope walk for women. We expect men to be strong & capable, but women to be warm & modest too. We mistake their assertiveness for selfishness and vulnerability for weakness. We should hold all leaders to common standards of competence…
Impact of primary tumor sidedness and sex on prognosis and anti-EGFR efficacy in BRAF-mutant mCRC @ESMO_Open doi.org/10.1016/j.esmo… 🔎 pooled analysis of FIRE-1, CIOX, FIRE-3, XELAVIRI, & VOLFI 👉Benefit in LSPT 👉Worse outcome in RSPT 🧐hypothesis-generating.... @myESMO
#youngoncologists were killing it in the breast mini-orals session #ESMO24❗️❗️ Shoutout to all established investigators: give them the stage and they won’t disappoint! #Mentorship #ESMO4carers @myESMO @Prof_Nadia_H @lab_kok #ESMOAmbassadors
Having trouble staying on top of everything that is happening during #ESMO24? @OncoAlert 🚨 has got you covered! You find the link to sign up for the newsletter below 👇
The @OncoAlert 🚨 #ESMO24 DAILY Newsletter DAY TWO OUT TOMORROW MORNING SIGN UP TO RECEIVE IT Oncoalert360.com or oncoalert.m-pages.com/nhMpwe/oncoale… COVERING: ✅Cachexia tx Ponsegromab (NEJM) ✅POD1UM #AnalCancer ✅ENGOT-cx11 #CervicalCancer ✅LEAP 012 #HCC ✅MARIPOSA2🦋🫁…
#ESMO24 @myESMO Presidential Session I🥇 #anal #cancer POD1UM-303/InterAACT2 - Dr. Sheela Rao 📌n=308, ph 3🌎1L advanced anal SCC carbo/taxolx6 +/- PD1-retifanlimab 1:1 (w/ crossover 35%) 📌 n=308, ~75%F, ~80%M1, 3% HIV+,90% PDL1+ ➡️mPFS 9.3 v 7.4m, HR 0.63, p=0.0006 (primary)…
Just Out on @JAMAOnc Patient Page: Caring for Your Heart❤️During Cancer Treatment by our #OncoAlertAF 🚨Colleague @lungoncdoc 🇺🇸and Team @ManuMysore2 @DylanSinghi Cardio-oncology is a specialized field that focuses on managing heart health in individuals undergoing #Cancer…
Stay tuned! @OncoAlert 🚨 has got you covered during #ESMO24!
Barcelona 🇪🇸 #ESMO24 We Are There🚨 For Colleagues....By Colleagues #OncoAlertAF @nataliagandur @acampsmalea @BiagioRicciutMD @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo @Abdallah81MD @FernandoOnco @ElisaAgostinett @to_be_elizabeth @lungoncdoc @bavilima…
The @OncoAlert 🚨 coverage of the last week is out, including a very interesting article on corticosteroids and checkpoint inhibitors!
The @OncoAlert 🚨Newsletter NOW OUT Covering August 8-15, 2024 REGISTER at Oncoalert360.com or oncoalert.m-pages.com/nhMpwe/oncoale… Discussing ✅Corticosteroids💊 and checkpoint inhibitors ✅GPX4 & HDAC inhibitors in #LungCancer 🫁 ✅SENOMAC in #BreastCancer 🇸🇪…
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials out on @JCO_ASCO Study investigates the impact of immunosuppressive treatment💊 on survival in patients with various tumor types receiving anti–PD-1 +…
I am back after taking a break from #socialmedia. The exhaustion of working on an ICU & trying to keep an academic career going, caught up on me. I needed to breathe… I apologize to my amazing colleagues from the @OncoAlert 🚨associate faculty whom I left unannounced 🫣
I am dreading my return back to work tomorrow after 3 weeks on sick leave and 1 week of vacation. Also happy to again be able to care for my patients. Please think about yourselves and take care of your mental health.
Nothing to add here! @OncoAlert 🚨
We must hold oncologists treating colorectal cancer to the same biomarker testing standards that we would expect in mgmt of breast cancer It is UNACCEPTABLE to treat mCRC without knowing: ✅ kras/nras/braf ✅ MMR/MSI ✅ her2 Yet fewer than 2/3rds of patients get this testing!
This review on long-term toxicities from cancer therapy covering the “classic side effects” plus financial toxicity and psychosocial needs published in @NatRevClinOncol by @maryam_lustberg @NicoleKuderer @ADesaiMD @crisbergerot and @gary_lyman is a must read 👇 @OncoAlert 🚨
In a Review now published online, @maryam_lustberg @NicoleKuderer @ADesaiMD @crisbergerot and @gary_lyman discuss the mitigation of long-term toxicities from cancer treatment, including financial toxicity and psychosocial needs: nature.com/articles/s4157…
Still four days left to vote for @Prof_Nadia_H for @myESMO president!!
I almost always agree with @MyriamChalabi 🇳🇱 I COMPLETELY agree with OUR choice for @myESMO PRESIDENT in @Prof_Nadia_H 🇩🇪 #STRONG #WOMENLEADERS #PRESIDENT DONT FORGET TO VOTE 🗳️ esmo.org/about-esmo/how…
Mark your calendars for @myESMO deep dive on #BreastCancer‼️
DO NOT MISS TOMORROW Thursday 6:30pm CET @myESMO DEEP DIVE: #BreastCancer ✅ @Prof_Nadia_H 🇩🇪Breast Center director of the Breast Center at @LMU_Muenchen ✅ @TanjaGagliardi 🇬🇧 ✅suzette delaloge 🇫🇷 ✅Shani Paluch-Shimon 🇮🇱 KUDOS on the FACULTY ESMO!!
Watch out for the complete #ASCO24 coverage brought to you by @OncoAlert 🚨 Link to register 👇
The @OncoAlert 🚨COVERAGE For the COMPLETE #ASCO24 Congress is COMING SOON and DELIVERED TO YOU IN YOUR INBOX 📨 REGISTER at Oncoalert360.com or oncoalert.m-pages.com/nhMpwe/oncoale… #OncoAlertAF @nataliagandur @acampsmalea @MartaPerachino @heinrich_kat @BiagioRicciutMD…
#WomenInScience! It is fantastic to see so many #rolemodels in one picture 😍 @OncoAlert 🚨#ASCO24
“Fight for the things that you care about, but do it in a way that will lead others to join you.” RBG @OncoAlert 🚨is PROUD and We are Allies #WomenInScience Leaders Special Recognition Here to our Faculty @HopeRugo 🇺🇸 @Prof_Nadia_H 🇩🇪 @marinagarassino 🇺🇸 @ErikaHamilton9 🇺🇸 in…
🔥PLENARY Session #ASCO24🔥 Perioperative chemotherapy (FLOT) to neoadjuvant chemoradiation (CROSS) in patients with adenocarcinoma of the esophagus 🔎 ESOPEC phase III trial, 438 patients 👉R0 180 vs 171 👉pCR 17 vs 10% 👉mOS 66 vs 37 mo 👉3yr OS: 57.4 vs 50.7% 🧐FLOT improves…
The long awaited results of ESOPEC! #ASCO24 @OncoAlert 🚨
ESOPEC establishes FLOT as new SOC in patients with adenocarcinoma of the esophagus. #ASCO24 @OncoAlert 🚨
United States Trends
- 1. Kendrick 429 B posts
- 2. #AskShadow 13,9 B posts
- 3. Luther 34 B posts
- 4. Daniel Jones 43,9 B posts
- 5. $CUTO 5.609 posts
- 6. Drake 66,1 B posts
- 7. Squabble Up 20,1 B posts
- 8. Kdot 6.969 posts
- 9. Wayne 45,9 B posts
- 10. TV Off 27,2 B posts
- 11. Giants 76 B posts
- 12. Dodger Blue 8.709 posts
- 13. MSNBC 162 B posts
- 14. Kenny 23,1 B posts
- 15. #TSTTPDSnowGlobe 4.858 posts
- 16. Reincarnated 25,5 B posts
- 17. #AyoNicki 3.403 posts
- 18. Gloria 44,2 B posts
- 19. One Mic 4.335 posts
- 20. Wacced Out Murals 27,6 B posts
Who to follow
-
Ben Westphalen
@BenWestphalen -
Lizzy Smyth
@LizzySmyth1 -
Antonio D'Alessio
@A_DAlessioMD -
Florian Lordick
@FlorianLordick -
Yelena Y. Janjigian MD
@YJanjigianMD -
Sophia Stock
@SophiaStock_ -
Arbeitsgemeinschaft Internistische Onkologie - AIO
@AIO_Onkologie -
Kohei shitara
@KoheiShitara -
Sara Lonardi
@sara_lonardi1 -
LMU Klinikum München Hämatologie und Onkologie
@LMU_HaemOnk -
Myriam Chalabi
@MyriamChalabi -
Antonella Cammarota
@A_Cammarota_ -
ILSON David
@ILSONDavid -
DGHO e. V.
@dgho_eV -
giuseppe viscardi
@giusvisc
Something went wrong.
Something went wrong.